Wang Yu Gary Ng
CIK: 0001896252
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAGE
Niagen Bioscience, Inc.
Director
Discretionary Trading P&L
Holdings
About Ng Wang Yu Gary
Ng Wang Yu Gary (SEC CIK 0001896252) files insider reports with the SEC as Director of Niagen Bioscience, Inc. (NAGE).
Signal8 holds 2 ownership filings by Ng Wang Yu Gary, all Form 4s, filed between Jun 25, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 24, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ng Wang Yu Gary's filings is in LOS ANGELES, CA.
Recent filings by Ng Wang Yu Gary
Other insiders filing for Niagen Bioscience, Inc. (NAGE)
- Lopez Carlos Luis, SVP, General Counsel
- Pamir Ozan, Chief Financial Officer
- Fried Robert N, Chief Executive Officer
- YU Wing Tak Wendy, Director
- Cohen Ann, Director
- Patrick Kristin, Director